New hip stem tested for Long-Term stability
NCT ID NCT05848024
First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 35 times
Summary
This study is tracking 100 people who received a total hip replacement with a specific implant called AMIStem C. The main goal is to see how much the implant moves inside the bone over time, using special X-ray analysis. Researchers will also check how well patients recover and how long the implant lasts, up to 10 years after surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TOTAL HIP ARTHROPLASTY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hôpital privé Arras Les Bonnettes
Arras, France
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
AMIStem C cemented femoral stem (hip implant)
What this could lead to
If successful, this could confirm that the AMIStem C stem is stable and durable for long-term hip replacement, potentially improving surgical outcomes.
What could go wrong
This is a small, single-center, non-randomized study with no control group, so results may not apply broadly. The primary outcome is based on imaging analysis, not direct patient benefit.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.